Clinical Factors Affecting Lipid Metabolism and Optimal Dose of Heparin in Preterm Infants on Parenteral Nutrition
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Preterm infants on parenteral nutrition are at a relatively high risk for hypertriglyceridemia because they have immature lipoprotein lipase activity. The purpose of this study was to analyze the clinical factors affecting lipid metabolism in preterm infants receiving parenteral nutrition and to evaluate the influence of intravenous heparin on serum triglycerides to determine the adequate heparin dose to prevent hypertriglyceridemia in preterm infants. Methods: A single-center retrospective review was conducted among preterm infants receiving parenteral nutrition between January 2006 and February 2011. In 75 patients, 110 determinations were performed within 28 days postnatal age. Demographic and clinical data, including laboratory parameters, the dose and the duration of lipid administration, and the amount of intravenous heparin, were analyzed. Results: Serum triglycerides were higher in the small for gestational age (SGA) infants than in the appropriate for gestational age infants (185.5±134.9 mg/dL vs. 126.9±101.9 mg/dL, p=0.019). Birth weight, gestational age, and body weight were negatively correlated with serum triglyceride level (r=−0.289, p=0.002; r=−0.208, p=0.029; r=−0.287, p=0.002, respectively). The serum triglyceride level was statistically lower in preterm infants receiving 1 U/mL of heparin than in those receiving 0.5 U/mL heparin or no heparin. Conclusion: Preterm infants receiving parenteral nutrition, particularly SGA and extremely low birth weight infants, tend to have hypertriglyceridemia. Thus, administration of 1 U/mL of heparin rather than 0.5 U/mL or none may be helpful to prevent hypertriglyceridemia in preterm infants. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 116∼122)
Abstract
Purpose: Preterm infants on parenteral nutrition are at a relatively high risk for hypertriglyceridemia because they have immature lipoprotein lipase activity. The purpose of this study was to analyze the clinical factors affecting lipid metabolism in preterm infants receiving parenteral nutrition and to evaluate the influence of intravenous heparin on serum triglycerides to determine the adequate heparin dose to prevent hypertriglyceridemia in preterm infants. Methods: A single-center retrospective review was conducted among preterm infants receiving parenteral nutrition between January 2006 and February 2011. In 75 patients, 110 determinations were performed within 28 days postnatal age. Demographic and clinical data, including laboratory parameters, the dose and the duration of lipid administration, and the amount of intravenous heparin, were analyzed. Results: Serum triglycerides were higher in the small for gestational age (SGA) infants than in the appropriate for gestational age infants (185.5±134.9 mg/dL vs. 126.9±101.9 mg/dL, p=0.019). Birth weight, gestational age, and body weight were negatively correlated with serum triglyceride level (r=−0.289, p=0.002; r=−0.208, p=0.029; r=−0.287, p=0.002, respectively). The serum triglyceride level was statistically lower in preterm infants receiving 1 U/mL of heparin than in those receiving 0.5 U/mL heparin or no heparin. Conclusion: Preterm infants receiving parenteral nutrition, particularly SGA and extremely low birth weight infants, tend to have hypertriglyceridemia. Thus, administration of 1 U/mL of heparin rather than 0.5 U/mL or none may be helpful to prevent hypertriglyceridemia in preterm infants. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 116∼122)
참고문헌 (16)
- Shennan AT, "The effect of gestational age on intralipid tolerance in newborn infants", J Pediatr, 91, pp.134~137 (1977)
- Andrew G, "Lipid metabolism in the neonate. I. The effects of Intralipid infusion on plasma triglyceride and free fatty acid concentrations in the neonate", J Pediatr, 88, pp.273~278 (1976)
- Adamkin DH, "Fat emulsions and hypertriglyceridemia", JPEN J Parenter Enteral Nutr, 8, pp.563~567 (1984)
- Wang H, "Lipoprotein lipase: from gene to obesity", Am J Physiol Endocrinol Metab, 297, pp.E271~288 (2009)
- "Postheparin plasma lipoprotein and hepatic lipases in preterm neonates", Pediatr Res, 18, pp.1104~1107 (1984)
- Simmer K, "Early introduction of lipids to parenterally- fed preterm infants", Cochrane Database Syst Rev, 2 (2005)
- 윤은실, "비만아에서 비알코올성 지방간염의 위험요인", Pediatric Gastroenterology, Hepatology & Nutrition, 10(2), pp.179~184 (2007), 대한소아소화기영양학회
- Hong YM, "Correlation between High Blood Pressure and Lipid Profile in School Children", J Korean Pediatr Soc, 38, pp.1645~1652 (1995)
- Rovamo LM, "Lipoprotein lipase, hepatic lipase, and carnitine in premature infants", Arch Dis Child, 63, pp.140~147 (1988)
- Zhang L, "Calcium triggers folding of lipoprotein lipase into active dimers", J Biol Chem, 280, pp.42580~42591 (2005)
- Magkos F, "Gender differences in lipid metabolism and the effect of obesity", Obstet Gynecol Clin North Am, 36, pp.245~265 (2009)
- Drenckpohl D, "Randomized trial of very low birth weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week of life", Pediatrics, 122, pp.743~751 (2008)
- Connelly PW, "The role of hepatic lipase in lipoprotein metabolism", Clin Chim Acta, 286, pp.243~255 (1999)
- Neuger L, "Effects of heparin on the uptake of lipoprotein lipase in rat liver", BMC Physiol, 4, pp.13~ (2004)
- Shah PS, "Heparin for prolonging peripheral intravenous catheter use in neonates", Cochrane Database Syst Rev, 4 (2005)
- Silvers KM, "Pharmacologic levels of heparin do not destabilize neonatal parenteral nutrition", JPEN J Parenter Enteral Nutr, 22, pp.311~314 (1998)